# Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

> **NCT07396467** · — · ACTIVE_NOT_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)
- Pulmonary Fibrosis
- Interstitial Lung Diseases

## Interventions

- **OTHER:** there is no intervention

## Key facts

- **NCT ID:** NCT07396467
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396467, "Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07396467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*